Who is sponsoring NCT05826158?

NCT05826158 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT05826158?

Interventions in NCT05826158: 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT).

What condition does NCT05826158 study?

NCT05826158 studies Neuroblastoma.

Is NCT05826158 still recruiting?

NCT05826158 is currently recruiting now. Last updated 15 November 2024.

Last reviewed 2024-11-15 · How we verify

NCT05826158

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

Recruiting now NA Last updated 15 November 2024

What this trial tests

NA trial testing 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT) in Neuroblastoma in 25 participants. Currently enrolling.

Timeline

6 June 2022

Primary endpoint
1 September 2025

31 December 2025

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	25
Start date	6 June 2022
Primary completion	1 September 2025
Estimated completion	31 December 2025
Sites	1 location across Denmark

Drugs / interventions tested

18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT)

Conditions studied

Neuroblastoma — all drugs for Neuroblastoma →

Sponsor

Rigshospitalet, Denmark

Who can join

Under 18, any sex, with Neuroblastoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study evaluating the positron-emitting radiopharmaceutical 18F-mFBG compared to 123I-mIBG scintigraphy for imaging of neuroblastoma

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Performing [<sup>18</sup>F]MFBG Long-Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma.
Borgwardt L, Brok J, Andersen KF, Madsen J, et al · · 2024 · cited 20× · PMID 38960713 · DOI 10.2967/jnumed.123.267256
Pathways and challenges in the clinical translational of radiopharmaceuticals for pediatric investigations.
Stauff E, Karimi H, Kecskemethy HH, Shaffer TH, et al · · 2025 · PMID 41282032 · DOI 10.3389/fmed.2025.1658588

Verify or expand the search:

Other recruiting trials for Neuroblastoma

Currently open trials in the same condition.

NCT07399821 — An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma · Phase 1, PHASE2 · recruiting
NCT06995872 — Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refra · Phase 1 · recruiting
NCT06942039 — Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · EARLY_PHASE1 · recruiting
NCT07067346 — Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma · EARLY_PHASE1 · recruiting
NCT07027748 — Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or R · Phase 1 · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05826158 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 15 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05826158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing